相关实验视频

Updated: May 5, 2026

Microfluidic On-chip Capture-cycloaddition Reaction to Reversibly Immobilize Small Molecules or Multi-component Structures for Biosensor Applications

Microfluidic On-chip Capture-cycloaddition Reaction to Reversibly Immobilize Small Molecules or Multi-component Structures for Biosensor Applications

Published on: September 23, 2013

对TLR7激动剂SZU-106的物理化学和生物特性

Martin Herbst¹, Johannes Kipp¹, Sonja M Kessler¹

¹Institute of Pharmacy, Martin-Luther-University Halle-Wittenberg, Kurt-Mothes-Str. 3, 06120, Halle, Germany.

Pharmaceutical research

|February 25, 2026

概括

SZU-106是一种新型的托尔类受体7 (TLR7) 激动剂,在中性溶液中具有性和稳定性,但在酸性/性条件下降解. 它没有显著的细胞毒性,支持其作为治疗TLR7激动剂的发展.

科学领域:

免疫学免疫学免疫学
药理学药理学是指药理学的学科.
药物开发药物开发

背景情况:

收费类受体7 (TLR7) 对于抗病毒免疫反应至关重要.
SZU-106是一种新开发的TLR7激动剂,具有潜在的治疗应用.

研究的目的:

描述SZU-106.6的物理化学和生物特性.
评估其适用于药物产品开发的适用性.

主要方法:

在和实验测定分布系数 (LogD).
在各种pH和温度条件下进行应力稳定性测试.
HPLC ESI-MS/MS用于降解产品的识别.
使用THP-1单细胞和巨细胞进行细胞毒性测定.

主要成果:

SZU-106主要是水友性的.
该化合物在中性水溶液中稳定,但在酸性和基本性条件下迅速降解.
降解通过氨基酸键的水解性裂变发生,确定了四种主要产物.
没有观察到显著的非目标细胞毒性,只有轻微的,时间依赖的,高度的受体介导作用.

结论:

SZU-106对药物开发具有有利的物理化学和生物特性.
这种TLR7激动剂的进一步开发,包括配方策略,是有必要的.

关键词:

托尔类受体7 (TLR7) 激活剂细胞毒性测定试验药物的稳定性药物的稳定性

更多相关视频

Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells

Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells

Published on: April 9, 2018

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

相关概念视频

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...